Fosigotifator by Calico Life Sciences for Unspecified Central Nervous System Disorders: Likelihood of Approval

Fosigotifator is under clinical development by Calico Life Sciences and currently in Phase II for Unspecified Central Nervous System Disorders.

Dr. Glaucomflecken uses humor to spotlight the darkness in medicine

Even if you don’t use TikTok, you’ve probably come across Will Flanary, aka Dr. Glaucomflecken, the internet’s most famous physician/comedian. For more than four years,

December 18, 2024

FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS | Psychedelic Invest

Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, today announced that Maureen O’Connell has stepped

January 3, 2024

Pharmalittle: We’re reading about a Vertex pain pill, an abortion pill hearing, and more

Top of the morning to you. And a fine one it is. Despite gray skies, the temperature is gradually rising and a large family of

January 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.